Fonteyne Paul R.

Fonteyne Paul R. is listed in filings as Director at Apellis Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 14, 2026, including 12 public disclosures. Recent filings connect the profile to Apellis Pharmaceuticals, Inc. (APLS) and Amylyx Pharmaceuticals, Inc. (AMLX). The current snapshot covers public activity from Jun 9, 2025 to May 14, 2026. Reported amounts are shown as $1.6M to $404.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.